testicular neoplasms

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Tumors, Endometrial Tumors, NSCLC Trial in United Kingdom, United States (SGN-ALPV)

Recruiting
  • Ovarian Neoplasms
  • +5 more
  • Fresno, California
  • +10 more
Jan 20, 2023

Lymphedema After Urologic Surgery

Recruiting
  • Urinary Bladder Neoplasms
  • +2 more
  • Self-reported lymphedema
  • +2 more
  • Göteborg, Sweden
    Sahlgrenska University Hospital
Mar 16, 2022

Role of Axumin PET Scan in Germ Cell Tumor

Active, not recruiting
  • Testis Cancer
  • +12 more
  • Axumin PET scan
  • Dallas, Texas
    UT Southwestern Medical Center
Nov 5, 2021

Testicular Tumors Trial in Agri (Testicular Model BSE/TSE Training Set)

Active, not recruiting
  • Testicular Neoplasms
  • Testicular Model BSE/TSE Training Set
  • Agri, Turkey
    Agri Ibrahim Cecen University
Sep 25, 2021

Testicular Tumors Trial in St.Gallen

Recruiting
  • Testicular Neoplasms
    • St.Gallen, Switzerland
      Kantonsspital St.Gallen; Onkologie/Haematologie
    Jul 27, 2021

    Venous Thromboembolism in Patients Receiving First-Line

    Completed
    • Testicular Neoplasms
    • Review of Health Information
    • Parkville, Victoria, Australia
      Walter and Eliza Hall Institute of Medical Research
    Oct 15, 2020

    The Platinum Study Comparison Group

    Completed
    • Testicular Neoplasms
    • Questionnaire
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Cancer Center
    Apr 7, 2020

    Tumors, Lung Tumors, Colon Tumors Trial in Idaho Falls (Provider determined)

    Terminated
    • Neoplasms
    • +24 more
    • Provider determined
    • Idaho Falls, Idaho
      Teton Cancer Institute
    Mar 29, 2019

    Testicular Tumors, Tumors, Germ Cell and Embryonal, Tumors Trial in Bratislava (Avelumab)

    Completed
    • Testicular Neoplasms
    • +6 more
    • Bratislava, Slovakia
      National Cancer Institute
    Mar 3, 2019

    End of Life, Advanced Cancer, Lung Tumor Trial (EPAC)

    Completed
    • End of Life
    • +13 more
    • EPAC
    • (no location specified)
    Oct 4, 2018

    Neuronal-like Cells From Cisplatin-Induced Peripheral Neuropathy

    Withdrawn
    • Peripheral Nervous System Diseases
    • Testicular Neoplasms
    • Blood sample collection
    • Report of peripheral neuropathy after cisplatin therapy
    • Indianapolis, Indiana
      IU Simon Cancer Center
    Feb 27, 2018

    Quality of Life Among Testicular Cancer Survivors

    Unknown status
    • Testicular Neoplasms
    • +3 more
    • Questionnaires
    • Hormonal Function measurement
    • Petah Tikva, Israel
      Rabin Medical Center, Beilinson & Hasharon Hospitals
    Oct 15, 2017

    Cardiovascular Diseases, Testicular Tumors Trial (High-intensity aerobic interval exercise)

    Completed
    • Cardiovascular Diseases
    • Testicular Neoplasms
    • High-intensity aerobic interval exercise
    • (no location specified)
    Apr 20, 2017

    Testicular Tumors Trial in Oslo (Exercise group, Control group)

    Terminated
    • Testicular Neoplasms
    • Exercise group
    • Control group
    • Oslo, Norway
      Oslo University Hospital
    Jan 25, 2017

    Sarcoma, Multiple Myeloma, Testicular Tumors Trial in Edmonton (Positron Emission Tomography)

    Completed
    • Sarcoma
    • +4 more
    • Positron Emission Tomography
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 24, 2016

    Testicular Tumors, Germ Cell Tumors Trial in Milano (Cyclophosphamide, Etoposide, Cisplatin)

    Completed
    • Testicular Neoplasms
    • Germ Cell Tumors
    • Milano, Italy
      Istituto Nazionale dei Tumori
    Jun 11, 2014

    Testicular Tumors Trial in Paris (epirubicin, high-dose and autologous stem cell transplantation, paclitaxel)

    Completed
    • Testicular Neoplasms
    • Paris, France
      Hôpital TENON, Service d'Oncologie Médicale
    Feb 24, 2011

    Breast Tumors, Lymphoma, Tumor Metastasis Trial run by the NCI (interleukin-1)

    Completed
    • Breast Neoplasms
    • +3 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008